Results of adjuvant interferon study in WHO melanoma programme

Lancet. 1994 Apr 9;343(8902):913-4. doi: 10.1016/s0140-6736(94)90030-2.
No abstract available

Publication types

  • Clinical Trial
  • Letter
  • Randomized Controlled Trial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Age Factors
  • Female
  • Humans
  • Interferon alpha-2
  • Interferon-alpha / therapeutic use*
  • Male
  • Melanoma / surgery
  • Melanoma / therapy*
  • Middle Aged
  • Recombinant Proteins
  • Sex Factors
  • Skin Neoplasms / surgery
  • Skin Neoplasms / therapy*
  • Survival Analysis

Substances

  • Interferon alpha-2
  • Interferon-alpha
  • Recombinant Proteins